Search Results
Feb 04, 2026, 16:41 ET Indonesia Targets Growing Indian Tourism Market through Wonderful Indonesia Showcase at OTM Mumbai and Chennai Sales Mission
attraction."This year, we're targeting a potential transaction worth IDR 48 billion and an estimated 40,000 Indian tourist arrivals," she said.The ministry last participated in OTM in 2024, generating approximately IDR 40.7 billion in potential transactions. In 2025, it was present at SATTE
More news about: The Ministry of Tourism of the Republic of Indonesia
Jan 02, 2026, 01:07 ET The Westin Surabaya Persembahkan "The Beauty of China ke 19" Sebuah Mahakarya Imlek Penuh Pesona
Scallop, Udang, dan Kismis; serta Four Season Cheng Teng & Onde Charcoal Hitam. Paket meja untuk sepuluh tamu tersedia mulai dari IDR 20.888.888++.Untuk informasi lebih lanjut dan reservasi meja, silakan menghubungi hotel di +62 31 2971 0000, serta
More news about: The Westin Surabaya
Dec 18, 2025, 11:15 ET Big Surprise for The No Surprises Act: Study Shows Insurer Benchmark Dangerously Lower Than In-Network Rate
subject to the Independent Dispute Resolution (IDR) process, the reported QPA was lower than the median in-network contracted amount. In those cases, networking rates were an average of 300% higher.In more than 60,000 disputes subject to the IDR process, the reported QPA is less than $20.
More news about: Americans for Fair Health Care (AFHC)
Dec 18, 2025, 07:30 ET Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford)
SGX942 (oral mucositis), is an innate defense regulator (IDR), a new class of short, synthetic peptides. It has a novel mechanism of action whereby it modulates the body's reaction to both injury and infection
More news about: SOLIGENIX, INC.
Dec 17, 2025, 07:30 ET Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
programs in this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's
More news about: SOLIGENIX, INC.
Dec 11, 2025, 07:38 ET NUTX Investors Have Opportunity to Join Nutex Health Inc. Fraud Investigation with the Schall Law Firm
submitting the majority of its patient bills to the arbitration process for settling out-of-network medical bills . . . using an unidentified 'third party IDR vendor.'" The report alleges that this "mystery consultant" engaged in improper or illegal activities "on behalf of and in conjunction with
More news about: The Schall Law Firm
Dec 04, 2025, 15:47 ET HaloMD Expands Executive Leadership to Further Strengthen Industry-Leading Data, Technology, and Compliance Operations as Independent and Rural Practices Continue to Face Operational Risk
America's Rural Healthcare Crisis a 2026 Outlook Driven by Reimbursement InstabilityThe NSA's Independent Dispute Resolution (IDR) process remains a critical mechanism for securing fair and reasonable reimbursement, enabling providers to preserve access to essential care in their
More news about: HaloMD
Dec 02, 2025, 13:57 ET Tria Enables Self-Custodied Bitcoin Top-Ups for Global Card Spending
the same time, several governments are advancing national stablecoin initiatives—such as JPYC in Japan, EURS in the Eurozone, and KRW-, IDR-, and PHP-denominated stablecoins in Asia—making multi-currency, on-chain financial infrastructure increasingly relevant.Tria is positioned at
More news about: Tria
Nov 25, 2025, 21:46 ET Pop the 90s: The Westin Surabaya dan Four Points Pakuwon Indah Sambut Tahun 2026 dengan Pertunjukan Spektakuler Bersama Project Pop
Seating: IDR 1.200.000++ per orang (termasuk sparkling wine untuk toast countdown) Main Dining Seating: IDR 888.000++ per orang Penampilan Spesial: Duo Saxo – Cendo & Friends 1 Januari 2026 – Brunch Buffet Pukul 12.00 – 15.00 WIB IDR 888.000++
More news about: Four Points by Sheraton Surabaya, Pakuwon Indah; The Westin Surabaya
Nov 19, 2025, 16:30 ET NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
success through the Independent Dispute Resolution (IDR) process. With regard to arbitration-related revenue: due to the continual underpayment from payors, we have continued to submit between 60-70% of our visits through the IDR process, we have won a legal determination on over
More news about: Nutex Health, Inc.
Nov 19, 2025, 07:30 ET Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
programs in this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's
More news about: SOLIGENIX, INC.
Nov 18, 2025, 18:50 ET NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
The Company believes its arbitration efforts through the Independent Dispute Resolution (IDR) process have resulted in an increase in fair and reasonable payments from insurance companies
More news about: Nutex Health, Inc.
Nov 18, 2025, 09:40 ET BUMA Strengthens Balance Sheet with Early Redemption of 7.75% 2026 Senior Notes
diversified financing strategy, ensuring continued access to multiple financing sources, including conventional and sharia bank facilities, Sukuk, USD and IDR bonds, and leasing. This balanced approach supports financial flexibility and positions BUMA to capitalize on future growth opportunities.
More news about: BUMA International Group
Nov 12, 2025, 13:00 ET HaloMD Announces Backing of Dr. Lorna Breen Heroes' Foundation Program to Support Mental Health of Healthcare Workers
HaloMD is the leading authority in Independent Dispute Resolution (IDR) under the federal No Surprises Act and state balance billing laws. Built exclusively for IDR, HaloMD delivers fair reimbursement and financial sustainability through proprietary technology, advanced
More news about: HaloMD
Nov 07, 2025, 07:30 ET Soligenix Announces Recent Accomplishments and Third Quarter 2025 Financial Results
programs in this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's
More news about: SOLIGENIX, INC.
Nov 06, 2025, 02:11 ET Kanazawa University research: Protein droplets in the nucleus guard against cancer
(IDRs) at its N- and C-termini and in the central region (A). The cancer-associated E1321 frameshift mutation results in the loss of the C-terminal IDR (B). In the nucleus, CHD1 forms liquid–liquid phase–separated condensates via its IDRs (C). HR-AFM imaging of purified CHD1 showed that these condensates
More news about: Kanazawa University
Nov 04, 2025, 16:14 ET Moody's and Fitch Upgrade Avianca's Credit Ratings on the back of Solid Performance and a Stronger Balance Sheet
upgraded Avianca's Corporate Family Rating (CFR) from B2 (B) to B1 (B+) with a Stable Outlook, and Fitch raised the company's Long-Term Issuer Default Rating (IDR) from B to B+ and maintained a Stable Outlook. Both Credit Agencies highlighted
More news about: Avianca Group International Limited - AGIL
Nov 03, 2025, 20:39 ET BRI Books Rp41,2 Trilion Profit, Reinforces Its Strategic Role in Driving the People's Economy
rising loan demand," he said. BRI's total assets grew 8,2% YoY reached IDR 2,123.4 trillion; loans rose 6.3% YoY to IDR 1,438.1 trillion; and third-party funds increased 8,2% YoY to IDR 1,474.8 trillion. The Current Account-Savings Account ratio improved to 67.6%, with capital and
More news about: PT Bank Rakyat Indonesia Tbk (BRI)
Oct 21, 2025, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2025 in Nutex Health Inc. Lawsuit - NUTX
third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process
More news about: Levi & Korsinsky, LLP
Oct 20, 2025, 08:45 ET Shareholders of Nutex Health Inc. Should Contact The Gross Law Firm Before October 21, 2025 to Discuss Your Rights - NUTX
third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process
More news about: The Gross Law Firm
Oct 18, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
appeals using the IDR process." In response, in July 2024, the Company engaged with HaloMD, a "third-party IDR vendor," to "assist in the recovery of certain out of network claims" in the IDR process. While Nutex did not disclose the identity of its third-party IDR vendor to investors
More news about: Pomerantz LLP
Oct 17, 2025, 08:45 ET Investors in Nutex Health Inc. Should Contact Levi & Korsinsky Before October 21, 2025 to Discuss Your Rights - NUTX
third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process
More news about: Levi & Korsinsky, LLP
Oct 16, 2025, 17:12 ET Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Oct 16, 2025, 09:00 ET The Gross Law Firm Notifies Shareholders of Nutex Health Inc.(NUTX) of a Class Action Lawsuit and an Upcoming Deadline
third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process
More news about: Gross Law Firm
Oct 15, 2025, 10:08 ET SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
(2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material
More news about: Faruqi & Faruqi, LLP